Ms. Yogita Patel is a recent graduate from McMaster University, and is currently the Clinical Research Lab Manager in Dr. Wael Hanna's Robotic Thoracic Surgery Research Lab in the Department of Surgery, Division of Thoracic Surgery at McMaster University / St. Joseph's Healthcare Hamilton in Hamilton, Ontario, Canada.

Michelle M. Turner, MS, CRNP has been an oncology nurse practitioner for over 18 years in the sub-specialties of GI, melanoma and thoracic malignancies. Her undergraduate studies were in biological sciences and after graduating from Wheaton College in Norton Ma, she went on to work on T and B cell research at Dana Farber Cancer Institute in Boston for 2 years prior to pursuing higher education. She received her master's degree from the Boston College School of Nursing and then went to work at the University of Maryland Medical Center in Baltimore MD in melanoma, GI and thoracic malignancies growing in her practice to achieve Lead Nurse Practitioner status and Associate Professor of Nursing from her many years of precepting NP students. She has had a passion for side effect management for oncology patients and over the years has given lectures nationally and internationally focusing on TKI toxicities and immune-toxicities.
In 2017 she went to Johns Hopkins University Kimmel Cancer Center Thoracic Center of Excellence as a Nurse Practitioner Manager where her administrative role allows for education and involvement in the advancement of clinic operations, NP staff and the development of an oncology urgent care center. In December 2020 she became the Advanced Practice Provider Manager for Johns Hopkins Solid Tumor Oncology which spans the campuses of Bayview, Downtown Johns Hopkins and Green Spring Station. In this position she adds value to the disease groups by initiating concepts for the group to function more effectively and efficiently and assumes fiscal responsibility with working knowledge of evidence based medical model.
Her current research focus is in the management of the long-term toxicities from immunotherapy treatment and received the 2021 Brager Award to help support this interest. She is a member of the International Association of the Study of Lung Cancer Nursing and Allied Health committee.
She is also the president of the Baltimore City Nurse Practitioner Group which meets monthly to discuss oncology topics and help colleagues at all levels network and collaborate across health systems.

Dr Anne-Marie Baird is a cancer molecular biologist, who has worked extensively on mesothelioma and lung cancer and is currently a Senior Research Fellow in Trinity College Dublin, Ireland. In 2021, Anne-Marie was elected as President of Lung Cancer Europe (LuCE), which is a non-profit umbrella organisation advocating for improved outcomes for people impacted by lung cancer. Anne-Marie is part of various scientific and advocacy groups/committees and is the outgoing chair of the IASLC Communications committee.